SOMA

LOE Approaching

carisoprodol

NDAORALCAPSULE
Approved
Apr 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

Pharmacologic Class:

Muscle Relaxant

Clinical Trials (5)

NCT06525389Phase 3Not Yet Recruiting

Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)

Started Apr 2026
428 enrolled
Talaromycosis
NCT07455864N/ARecruiting

Lysosomal Acid Lipase Deficiency in Risk Groups

Started Feb 2026
1,200 enrolled
Lysosomal Acid Lipase Deficiency
NCT07226089Phase 3Recruiting

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Started Feb 2026
254 enrolled
ISSSGA
NCT07080385Phase 2/3Recruiting

Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)

Started Jan 2026
28 enrolled
Autosomal Dominant Hypocalcemia Type 1 (ADH1)
NCT04901741Phase 2Not Yet Recruiting

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer

Started Jan 2026
60 enrolled
Metastatic Pancreatic Cancer
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.